Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients

Figure 3

Cumulative overall graft survival rate according to graft large droplet (Ld-MaS; (a-c)) and small-droplet (Sd-MaS; (b-d)) macrovesicular steatosis distribution in recipients with HCV unrelated ((a), (b)) and related ((c), (d)) liver disease.

(a)

(b)

(c)

(d)